Influenza virus-neutralizing antibody and screening method therefor


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Yoshikazu Kurosawa , Yoshitaka Iba , Nobuko OHSHIMA , Yoshinobu Okuno

ABSTRACT

Provided is an anti-influenza virus antibody that exhibits neutralizing activity beyond the barrier of the two groups of influenza viruses categorized according to the conservativeness of hemagglutinin amino acids, a method of producing the same, and a test method for determining whether the subject carries the neutralizing antibody.

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Yoshikazu Kurosawa", 
        "type": "Person"
      }, 
      {
        "name": "Yoshitaka Iba", 
        "type": "Person"
      }, 
      {
        "name": "Nobuko OHSHIMA", 
        "type": "Person"
      }, 
      {
        "name": "Yoshinobu Okuno", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nsmb.1574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004341513", 
          "https://doi.org/10.1038/nsmb.1574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0801367105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013741751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2010.02.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019142998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/289373a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032880486", 
          "https://doi.org/10.1038/289373a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nsmb.1566", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036779001", 
          "https://doi.org/10.1038/nsmb.1566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1205669", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043045872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.coviro.2012.02.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051706374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.2010.05829.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053253806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.2010.05829.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053253806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1099/0022-1317-62-1-153", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060354823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1171491", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062459980"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

Provided is an anti-influenza virus antibody that exhibits neutralizing activity beyond the barrier of the two groups of influenza viruses categorized according to the conservativeness of hemagglutinin amino acids, a method of producing the same, and a test method for determining whether the subject carries the neutralizing antibody.

", "id": "sg:patent.US-9605053-B2", "keywords": [ "neutralizing antibody", "screening method", "antibody", "barrier", "Orthomyxoviridae", "amino acid", "method" ], "name": "Influenza virus-neutralizing antibody and screening method therefor", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.136593.b", "type": "Organization" }, { "id": "https://www.grid.ac/institutes/grid.256115.4", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-9605053-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:34", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_b65d5aab.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-9605053-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-9605053-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-9605053-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-9605053-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

75 TRIPLES      14 PREDICATES      31 URIs      14 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-9605053-B2 schema:about anzsrc-for:3114
2 schema:author N1814e03e861e4947befd379f5abd716c
3 schema:citation sg:pub.10.1038/289373a0
4 sg:pub.10.1038/nsmb.1566
5 sg:pub.10.1038/nsmb.1574
6 https://doi.org/10.1016/j.bbrc.2010.02.031
7 https://doi.org/10.1016/j.coviro.2012.02.005
8 https://doi.org/10.1073/pnas.0801367105
9 https://doi.org/10.1099/0022-1317-62-1-153
10 https://doi.org/10.1111/j.1749-6632.2010.05829.x
11 https://doi.org/10.1126/science.1171491
12 https://doi.org/10.1126/science.1205669
13 schema:description <p id="p-0001" num="0000">Provided is an anti-influenza virus antibody that exhibits neutralizing activity beyond the barrier of the two groups of influenza viruses categorized according to the conservativeness of hemagglutinin amino acids, a method of producing the same, and a test method for determining whether the subject carries the neutralizing antibody.</p>
14 schema:keywords Orthomyxoviridae
15 amino acid
16 antibody
17 barrier
18 method
19 neutralizing antibody
20 screening method
21 schema:name Influenza virus-neutralizing antibody and screening method therefor
22 schema:recipient https://www.grid.ac/institutes/grid.136593.b
23 https://www.grid.ac/institutes/grid.256115.4
24 schema:sameAs https://app.dimensions.ai/details/patent/US-9605053-B2
25 schema:sdDatePublished 2019-03-07T15:34
26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
27 schema:sdPublisher Nae2bb605b5e64fd0aadfe6426438a7a9
28 sgo:license sg:explorer/license/
29 sgo:sdDataset patents
30 rdf:type sgo:Patent
31 N02458037f3a847bdacabf19a2b2708f1 rdf:first N4f4232f002b849a29ae4d283dd30670d
32 rdf:rest Nde6148d3d480439887c70b799c4ceae4
33 N1814e03e861e4947befd379f5abd716c rdf:first N89f3a519b10c481d8f606fabf6c83c1c
34 rdf:rest N3faca11cbccc497ebcd84d41f6bfc129
35 N3faca11cbccc497ebcd84d41f6bfc129 rdf:first N3fb4c4dcae2149b5bb718bea4677ae75
36 rdf:rest N02458037f3a847bdacabf19a2b2708f1
37 N3fb4c4dcae2149b5bb718bea4677ae75 schema:name Yoshitaka Iba
38 rdf:type schema:Person
39 N4f4232f002b849a29ae4d283dd30670d schema:name Nobuko OHSHIMA
40 rdf:type schema:Person
41 N89f3a519b10c481d8f606fabf6c83c1c schema:name Yoshikazu Kurosawa
42 rdf:type schema:Person
43 Nae2bb605b5e64fd0aadfe6426438a7a9 schema:name Springer Nature - SN SciGraph project
44 rdf:type schema:Organization
45 Nde6148d3d480439887c70b799c4ceae4 rdf:first Ne3eec351098042fca86c3f1f2ce3ee8d
46 rdf:rest rdf:nil
47 Ne3eec351098042fca86c3f1f2ce3ee8d schema:name Yoshinobu Okuno
48 rdf:type schema:Person
49 anzsrc-for:3114 schema:inDefinedTermSet anzsrc-for:
50 rdf:type schema:DefinedTerm
51 sg:pub.10.1038/289373a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032880486
52 https://doi.org/10.1038/289373a0
53 rdf:type schema:CreativeWork
54 sg:pub.10.1038/nsmb.1566 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036779001
55 https://doi.org/10.1038/nsmb.1566
56 rdf:type schema:CreativeWork
57 sg:pub.10.1038/nsmb.1574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004341513
58 https://doi.org/10.1038/nsmb.1574
59 rdf:type schema:CreativeWork
60 https://doi.org/10.1016/j.bbrc.2010.02.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019142998
61 rdf:type schema:CreativeWork
62 https://doi.org/10.1016/j.coviro.2012.02.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051706374
63 rdf:type schema:CreativeWork
64 https://doi.org/10.1073/pnas.0801367105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013741751
65 rdf:type schema:CreativeWork
66 https://doi.org/10.1099/0022-1317-62-1-153 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060354823
67 rdf:type schema:CreativeWork
68 https://doi.org/10.1111/j.1749-6632.2010.05829.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053253806
69 rdf:type schema:CreativeWork
70 https://doi.org/10.1126/science.1171491 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062459980
71 rdf:type schema:CreativeWork
72 https://doi.org/10.1126/science.1205669 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043045872
73 rdf:type schema:CreativeWork
74 https://www.grid.ac/institutes/grid.136593.b schema:Organization
75 https://www.grid.ac/institutes/grid.256115.4 schema:Organization
 




Preview window. Press ESC to close (or click here)


...